Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Robertson

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
British Journal of Pharmacology|July 1, 1992
Identification and distribution of 5-HT3 recognition sites in the rat gastrointestinal tractS Champaneria, B Costall, R J Naylor, et al.
Molecular Pharmacology|August 1, 1989
Analysis of the binding sites for the cardiotonic phosphodiesterase inhibitor [3H]LY186126 in ventricular myocardiumM Artman, D W Robertson, L Mahony, et al.
European Journal of Pharmacology|January 28, 1992
Sumatriptan and 5-benzyloxytryptamine: contractility of two 5-HT1D receptor ligands in canine saphenous veinsM L Cohen, K Schenck, D Nelson, et al.
Life Sciences|January 1, 1990
Depletion of cardiac norepinephrine but not brain catecholamines by MPTP-N-oxide in miceS K Hemrick-Luecke, D W Robertson, R W Fuller
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1987
Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brainR W Fuller, D W Robertson, S K Hemrick-Luecke
Research Communications in Chemical Pathology and Pharmacology|January 1, 1988
Comparative effects of 1-ethyl- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridines on catecholamine concentrations in mouse brain and heartR W Fuller, S K Hemrick-Luecke, D W Robertson
Life Sciences|January 1, 1992
mCPP but not TFMPP is an antagonist at cardiac 5HT3 receptorsD W Robertson, W Bloomquist, D T Wong, et al.
Journal of Pharmaceutical Sciences|May 1, 1994
Anticonvulsant properties of N-substituted alpha,alpha-diamino acid derivativesH Kohn, K N Sawhney, D W Robertson, et al.
General Pharmacology|October 1, 1994
5-HT4 receptors in rat but not guinea pig, rabbit or dog esophageal smooth muscleM L Cohen, A D Susemichel, W Bloomquist, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1986
Roles for Ca++ and cyclic AMP in mediating the cardiotonic actions of isomazole (LY175326)J S Hayes, N Bowling, G D Pollock, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
British Journal of Pharmacology|July 1, 1992
Identification and distribution of 5-HT3 recognition sites in the rat gastrointestinal tractS Champaneria, B Costall, R J Naylor, et al.
Molecular Pharmacology|August 1, 1989
Analysis of the binding sites for the cardiotonic phosphodiesterase inhibitor [3H]LY186126 in ventricular myocardiumM Artman, D W Robertson, L Mahony, et al.
European Journal of Pharmacology|January 28, 1992
Sumatriptan and 5-benzyloxytryptamine: contractility of two 5-HT1D receptor ligands in canine saphenous veinsM L Cohen, K Schenck, D Nelson, et al.
Life Sciences|January 1, 1990
Depletion of cardiac norepinephrine but not brain catecholamines by MPTP-N-oxide in miceS K Hemrick-Luecke, D W Robertson, R W Fuller
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1987
Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brainR W Fuller, D W Robertson, S K Hemrick-Luecke
Research Communications in Chemical Pathology and Pharmacology|January 1, 1988
Comparative effects of 1-ethyl- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridines on catecholamine concentrations in mouse brain and heartR W Fuller, S K Hemrick-Luecke, D W Robertson
Life Sciences|January 1, 1992
mCPP but not TFMPP is an antagonist at cardiac 5HT3 receptorsD W Robertson, W Bloomquist, D T Wong, et al.
Journal of Pharmaceutical Sciences|May 1, 1994
Anticonvulsant properties of N-substituted alpha,alpha-diamino acid derivativesH Kohn, K N Sawhney, D W Robertson, et al.
General Pharmacology|October 1, 1994
5-HT4 receptors in rat but not guinea pig, rabbit or dog esophageal smooth muscleM L Cohen, A D Susemichel, W Bloomquist, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1986
Roles for Ca++ and cyclic AMP in mediating the cardiotonic actions of isomazole (LY175326)J S Hayes, N Bowling, G D Pollock, et al.
Pageof 9